SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,810.00    115.00 (1.72%)
Bid:
6,770.00
Ask:
6,775.00
Spread: 5.00 (0.074%)
Market Cap: £5.03b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

13 May 2008 12:00

RNS Number : 3064U
Spirax-Sarco Engineering PLC
13 May 2008
 

Spirax-Sarco Engineering plc

Tuesday 13th May 2008 

INTERIM MANAGEMENT STATEMENT

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement in respect of the four month period ended 30th April 2008, ahead of its Annual General Meeting today at 2.00 pm.

Trading

Overall market conditions have remained favourable in 2008. We have seen sustained business investment by our customers and we continue to benefit from good progress with our ongoing sales initiatives.

The organic revenue growth trend has continued from last year through into 2008. Growth was spread across all geographic regions for both the Spirax Sarco and Watson-Marlow Bredel businesses. The euro has strengthened considerably since late last year which, together with other currency movements elsewhere, has benefited the translation into sterling of total Group revenues by approximately 6% overall, with a larger benefit to operating profit.

Corporate Developments

The integration of Flexicon with our Watson-Marlow Bredel business is proceeding well following completion of the acquisition on 11th February 2008 for £14m. As previously reported, Marcus Steel retired as Chief Executive as of 31st March 2008, as did Peter Smith, Director and Company Secretary. On 1st April Mark Vernon, previously Chief Operating Officer, succeeded Marcus as Chief Executive and William Stebbings succeeded Peter as Company Secretary.

Financial position

The Group started the year with net cash of £16m and has subsequently paid an initial £11m consideration for the acquisition of Flexicon. There has been no material change in the financial position of the Group during the period and we continue to operate with a strong balance sheet. As anticipated, we expect capital expenditure this year to be well above normal levels mainly due to the new premises in China.

 

Outlook

In our preliminary statement in early March, we reported that 2008 had started well and that, assuming our global markets remained stable, we expected to produce another good performance in 2008. Trading so far this year confirms this expectation, although there remains uncertainty about the resilience of the global economy, and in particular North America. If current exchange rates prevail for the remainder of the year, sales and profits, particularly in Continental Europe, will also benefit from good exchange gains.

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 521361

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBGGDUCSBGGIX
Date   Source Headline
4th Sep 201910:00 amRNSBoard Change
21st Aug 20192:49 pmRNSHolding(s) in Company
14th Aug 20199:02 amRNSHolding(s) in Company
9th Aug 201910:27 amRNSDirector/PDMR Shareholding
8th Aug 20194:26 pmRNSDirector/PDMR Shareholding
7th Aug 20197:00 amRNSHalf-year Report
1st Aug 20195:41 pmRNSChange of Adviser
28th May 20193:08 pmRNSHolding(s) in Company
17th May 20194:16 pmRNSDirector/PDMR Shareholding
16th May 20194:12 pmRNSHolding(s) in Company
15th May 20195:14 pmRNSResult of AGM
15th May 20197:05 amRNSBoard Changes
15th May 20197:00 amRNSAGM Statement - Trading Update
13th May 20192:45 pmRNSCompletion of Acquisition
30th Apr 20199:21 amRNSChange of Director Details
25th Apr 20198:28 amRNSChange of Director Details
11th Apr 20192:36 pmRNSDirector/PDMR Shareholding
15th Mar 201911:25 amRNSAcquisition
7th Mar 20197:00 amRNSFinal Results
1st Mar 20193:04 pmRNSBoard Appointment
18th Feb 20197:00 amRNSExclusive negotiations to acquire Thermocoax
16th Jan 20194:20 pmRNSChange of Director Details
3rd Dec 20187:00 amRNSDisposal
15th Nov 20187:00 amRNSTrading Update
31st Oct 20184:23 pmRNSDirector/PDMR Shareholding
12th Oct 20185:34 pmRNSDirector/PDMR Shareholding
26th Sep 20187:30 amRNSChange of Director Details
20th Sep 201811:16 amRNSHolding(s) in Company
23rd Aug 20184:55 pmRNSHolding(s) in Company
9th Aug 20183:07 pmRNSDirector/PDMR Shareholding
8th Aug 20187:00 amRNSHalf Year Results
31st Jul 201810:22 amRNSHolding(s) in Company
25th Jul 20189:46 amRNSChange of Director Details
20th Jul 201810:00 amRNSExecutive Director Promotion
11th Jun 20184:26 pmRNSHolding(s) in Company
31st May 20188:12 amRNSDirector/PDMR Shareholding
17th May 20189:26 amRNSDirector/PDMR Shareholding
15th May 20184:55 pmRNSResult of AGM
15th May 20187:00 amRNSAGM Statement - Trading Update
25th Apr 20184:27 pmRNSDirector/PDMR Shareholding
6th Apr 20183:32 pmRNSDirector/PDMR Shareholding
4th Apr 20184:17 pmRNSDirector/PDMR Shareholding
29th Mar 20184:24 pmRNSTotal Voting Rights
29th Mar 20184:20 pmRNSDirector/PDMR Shareholding
15th Mar 20187:00 amRNS2017 Preliminary Results
6th Mar 20187:00 amRNSBoard Appointment
14th Feb 20187:00 amRNSBoard Succession Changes
6th Feb 20187:30 amRNSChange of Director Details
20th Dec 20179:07 amRNSChange of Director Details
27th Nov 20174:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.